Keywords: actelion, increases, operating, revenues, 11-fold, switzerland, specialist
Actelion increases operating revenues 11-fold in 2000
Article | 14 February 2001
Actelion of Switzerland, a specialist in cardiovascular drugdevelopment, has reported operating revenues in calendar 2000 of 31.6 million Swiss francs ($19.1 million), an 11 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
